{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-260863","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.972231+00:00","generated_at":"2026-05-17T01:07:08.063590+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Chemours adopts new executive severance policy with 2.0x multiplier for CEO","bullets":["CEO severance: 2.0x sum of base salary, target annual incentive, and annualized health care subsidy; other execs 1.0x.","Payable on involuntary termination without Cause or resignation for Good Reason; requires signed release of claims.","Existing change-in-control agreements and equity award terms remain in effect; policy does not supersede them.","Policy effective October 28, 2025; administered by Board or Compensation Committee; amendment requires 12-month notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-260863","json":"https://secwatch.observer/filing/0001193125-25-260863.json","markdown":"https://secwatch.observer/filing/0001193125-25-260863.md","text":"https://secwatch.observer/filing/0001193125-25-260863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/0001193125-25-260863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000119312525260863/cc-20251028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:07:08.063590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}